Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05606016 · ClinicalTrials.gov registry record · NA

Examining How a Facilitated Self-Sampling Intervention and Testing Navigation Intervention Influences COVID-19 Testing

A NA study of COVID-19, sponsored by The University of Texas Health Science Center, Houston.

Completed
Registry status
NA
Development phase
1,232
Enrollment target
3
Study locations

NCT05606016 is a NA study of COVID-19 that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 1,232 participants, below the 55,208-participant average among 203 other COVID-19 trials with a reported enrollment target (98% lower). The trial reports 3 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05606016, a NA study of COVID-19, has completed, sponsored by The University of Texas Health Science Center, Houston.

COMPLETED
Registry status
NA
Development phase
1,232 participants
Enrollment target
3
Study locations

Study Summary

Antigen self-testing kits are more available at this stage in the pandemic, but among vulnerable populations, use is still low and instructions for antigen testing are not typically designed for low health literacy populations. Studies are needed to explore access and use of antigen tests among vulnerable populations and examine if low-health-literacy-designed interventions improve COVID-19 testing decisions and behaviors. This study will focus on understanding factors associated with rapid COVID-19 testing, specifically. The primary objectives of the embedded study are to 1) Determine the effectiveness of community-level intervention using door-to-door recruitment and education in increasing COVID-19 testing and 2) Compare the effectiveness of the CHW- Facilitated Self-Sampling Intervention (FSSI) vs. CHW Testing Navigation Intervention (TNI).

Conditions Studied

Interventions

  • BEHAVIORAL Control
  • BEHAVIORAL Facilitated Self-Sampling Intervention (FSSI)
  • BEHAVIORAL Testing Navigation Intervention (TNI).

Study Locations (3)

Texas

  • The University of Texas Health Science Center, Brownsville - Brownsville
  • The University of Texas Health Science Center, Houston - Houston
  • University of Texas Health Science Center,Tyler - Tyler

Trial Details

FieldValue
Enrollment Target 1,232 participants
Start Date 2023-03-30
Est. Completion 2024-08-14
Phase NA

What the Registry Record Tells You About NCT05606016

The ClinicalTrials.gov registry entry for NCT05606016 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,232 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 55,208-participant average among 203 other COVID-19 trials with a reported enrollment target (98% lower). The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with COVID-19 appearing as the primary indexed condition, and to 3 interventions - of which Control is the first listed.

NCT05606016 reports 3 study locations spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT05606016 about?

NCT05606016 is a clinical study titled "Examining How a Facilitated Self-Sampling Intervention and Testing Navigation Intervention Influences COVID-19 Testing". Antigen self-testing kits are more available at this stage in the pandemic, but among vulnerable populations, use is still low and instructions for antigen testing are not typically designed for low health literacy populations. Studies are needed to explore access and use of antigen tests among vuln...

What is the current status of trial NCT05606016?

This trial is currently completed. It is a NA study. The enrollment target is 1,232 participants. The study started on 2023-03-30. Estimated completion is 2024-08-14.

What conditions does trial NCT05606016 study?

This clinical trial studies the following conditions: COVID-19.

What interventions are being tested in trial NCT05606016?

The interventions under investigation include: Control (BEHAVIORAL), Facilitated Self-Sampling Intervention (FSSI) (BEHAVIORAL), Testing Navigation Intervention (TNI). (BEHAVIORAL).

Who is sponsoring clinical trial NCT05606016?

This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05606016 being conducted?

This trial has 3 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for COVID-19

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.